AC
FLAC

Athanor Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Athanor Capital’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-204,211
Closed -$2M – 217
2021
Q3 		$2M Sell
204,211
-100
-0% -$977 0.27% 94
2021
Q2 		$1.99M Hold
204,311
– – 0.07% 170
2021
Q1 		$2.03M Buy
+204,311
New +$2.08M 0.05% 230

Other funds holding FLAC

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

Athanor Capital's FLAC Position: Q4 2021 in Review

Athanor Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2021, closing a stake of 204,211 shares — an estimated $2M sold.

Athanor Capital first reported a position in FLAC in Q1 2021 and held it in 3 quarters. The position peaked at $2.03M in Q1 2021. 48 funds tracked by Wall St. Rank hold FLAC as of Q4 2021.

  • Athanor Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Athanor Capital sold 204,211 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2021, an estimated $2M.
  • Athanor Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
  • Athanor Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $2.03M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2021.

Based on Athanor Capital's 13F filing for Q4 2021, filed 14 Feb 2022.